Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
Identifieur interne : 000981 ( Main/Exploration ); précédent : 000980; suivant : 000982Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).
Auteurs : Nilfer Sahin [Turquie] ; Hatice Altun ; Ergül Belge Kuruta ; Ebru F Nd KlSource :
- Bosnian journal of basic medical sciences [ 1840-4812 ] ; 2018.
Descripteurs français
- KwdFr :
- MESH :
English descriptors
- KwdEn :
- MESH :
Abstract
Estrogen has a crucial role in the regulation of reproductive and neuroendocrine function and exerts its effects through two classes of receptors, nuclear and membrane estrogen receptors (mERs). G protein-coupled estrogen receptor 1 (GPER) is a member of mERs, and despite limited research on the levels of GPER in patients with psychiatric diseases, a role of GPER in such conditions has been suggested. Here we evaluated serum estrogen and GPER levels in children with attention deficit hyperactivity disorder (ADHD) in relation to their age- and gender-matched healthy controls. A total of 82 children were included in the study, 47 drug- naïve patients with ADHD (age: 6-12 years; male/female: 34/13) and 35 healthy controls (age: 6-12 years; male/female: 19/16). The subgroups according to ADHD types were inattentive, hyperactive/impulsive, and combined. Serum estrogen was measured using an immunoassay system, while serum GPER was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Estrogen levels in children with ADHD were similar as in control group, while GPER levels were significantly lower in ADHD group compared to controls (p < 0.05). Logistic regression analysis showed a significant association between GPER levels and ADHD (p < 0.05), and no association between estrogen levels and ADHD (p > 0.05). No significant differences were found in GPER and estrogen levels between ADHD subgroups (p > 0.05). To the best of our knowledge, this study is the first to investigate estrogen and GPER levels in ADHD. Our preliminary findings suggest a relationship between serum GPER levels and ADHD, and this should be further investigated.
DOI: 10.17305/bjbms.2018.2942
PubMed: 29659348
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000931
- to stream PubMed, to step Curation: 000931
- to stream PubMed, to step Checkpoint: 000926
- to stream Ncbi, to step Merge: 001E01
- to stream Ncbi, to step Curation: 001E01
- to stream Ncbi, to step Checkpoint: 001E01
- to stream Main, to step Merge: 000984
- to stream Main, to step Curation: 000981
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).</title>
<author><name sortKey="Sahin, Nilfer" sort="Sahin, Nilfer" uniqKey="Sahin N" first="Nilfer" last="Sahin">Nilfer Sahin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. nilfersahin@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla</wicri:regionArea>
<wicri:noRegion>Mugla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Altun, Hatice" sort="Altun, Hatice" uniqKey="Altun H" first="Hatice" last="Altun">Hatice Altun</name>
</author>
<author><name sortKey="Kuruta, Ergul Belge" sort="Kuruta, Ergul Belge" uniqKey="Kuruta E" first="Ergül Belge" last="Kuruta">Ergül Belge Kuruta</name>
</author>
<author><name sortKey="F Nd Kl, Ebru" sort="F Nd Kl, Ebru" uniqKey="F Nd Kl E" first="Ebru" last="F Nd Kl">Ebru F Nd Kl</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29659348</idno>
<idno type="pmid">29659348</idno>
<idno type="doi">10.17305/bjbms.2018.2942</idno>
<idno type="wicri:Area/PubMed/Corpus">000931</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000931</idno>
<idno type="wicri:Area/PubMed/Curation">000931</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000931</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000926</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000926</idno>
<idno type="wicri:Area/Ncbi/Merge">001E01</idno>
<idno type="wicri:Area/Ncbi/Curation">001E01</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001E01</idno>
<idno type="wicri:Area/Main/Merge">000984</idno>
<idno type="wicri:Area/Main/Curation">000981</idno>
<idno type="wicri:Area/Main/Exploration">000981</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD).</title>
<author><name sortKey="Sahin, Nilfer" sort="Sahin, Nilfer" uniqKey="Sahin N" first="Nilfer" last="Sahin">Nilfer Sahin</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla, Turkey. nilfersahin@hotmail.com.</nlm:affiliation>
<country xml:lang="fr">Turquie</country>
<wicri:regionArea>Department of Child and Adolescent Psychiatry, School of Medicine, Mugla Sitki Kocman University, Mugla</wicri:regionArea>
<wicri:noRegion>Mugla</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Altun, Hatice" sort="Altun, Hatice" uniqKey="Altun H" first="Hatice" last="Altun">Hatice Altun</name>
</author>
<author><name sortKey="Kuruta, Ergul Belge" sort="Kuruta, Ergul Belge" uniqKey="Kuruta E" first="Ergül Belge" last="Kuruta">Ergül Belge Kuruta</name>
</author>
<author><name sortKey="F Nd Kl, Ebru" sort="F Nd Kl, Ebru" uniqKey="F Nd Kl E" first="Ebru" last="F Nd Kl">Ebru F Nd Kl</name>
</author>
</analytic>
<series><title level="j">Bosnian journal of basic medical sciences</title>
<idno type="eISSN">1840-4812</idno>
<imprint><date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity (blood)</term>
<term>Case-Control Studies</term>
<term>Child</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Estradiol (blood)</term>
<term>Estrogens (blood)</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Receptors, Estrogen (blood)</term>
<term>Receptors, G-Protein-Coupled (blood)</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Analyse de régression</term>
<term>Enfant</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Oestradiol (sang)</term>
<term>Oestrogènes (sang)</term>
<term>Récepteurs couplés aux protéines G (sang)</term>
<term>Récepteurs des oestrogènes (sang)</term>
<term>Test ELISA</term>
<term>Trouble déficitaire de l'attention avec hyperactivité (sang)</term>
<term>Études cas-témoins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Estradiol</term>
<term>Estrogens</term>
<term>Receptors, Estrogen</term>
<term>Receptors, G-Protein-Coupled</term>
</keywords>
<keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Attention Deficit Disorder with Hyperactivity</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Oestradiol</term>
<term>Oestrogènes</term>
<term>Récepteurs couplés aux protéines G</term>
<term>Récepteurs des oestrogènes</term>
<term>Trouble déficitaire de l'attention avec hyperactivité</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term>
<term>Child</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Regression Analysis</term>
<term>Sex Factors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Analyse de régression</term>
<term>Enfant</term>
<term>Facteurs sexuels</term>
<term>Femelle</term>
<term>Humains</term>
<term>Mâle</term>
<term>Test ELISA</term>
<term>Études cas-témoins</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Estrogen has a crucial role in the regulation of reproductive and neuroendocrine function and exerts its effects through two classes of receptors, nuclear and membrane estrogen receptors (mERs). G protein-coupled estrogen receptor 1 (GPER) is a member of mERs, and despite limited research on the levels of GPER in patients with psychiatric diseases, a role of GPER in such conditions has been suggested. Here we evaluated serum estrogen and GPER levels in children with attention deficit hyperactivity disorder (ADHD) in relation to their age- and gender-matched healthy controls. A total of 82 children were included in the study, 47 drug- naïve patients with ADHD (age: 6-12 years; male/female: 34/13) and 35 healthy controls (age: 6-12 years; male/female: 19/16). The subgroups according to ADHD types were inattentive, hyperactive/impulsive, and combined. Serum estrogen was measured using an immunoassay system, while serum GPER was determined using a commercial sandwich enzyme-linked immunosorbent assay kit. Estrogen levels in children with ADHD were similar as in control group, while GPER levels were significantly lower in ADHD group compared to controls (p < 0.05). Logistic regression analysis showed a significant association between GPER levels and ADHD (p < 0.05), and no association between estrogen levels and ADHD (p > 0.05). No significant differences were found in GPER and estrogen levels between ADHD subgroups (p > 0.05). To the best of our knowledge, this study is the first to investigate estrogen and GPER levels in ADHD. Our preliminary findings suggest a relationship between serum GPER levels and ADHD, and this should be further investigated.</div>
</front>
</TEI>
<affiliations><list><country><li>Turquie</li>
</country>
</list>
<tree><noCountry><name sortKey="Altun, Hatice" sort="Altun, Hatice" uniqKey="Altun H" first="Hatice" last="Altun">Hatice Altun</name>
<name sortKey="F Nd Kl, Ebru" sort="F Nd Kl, Ebru" uniqKey="F Nd Kl E" first="Ebru" last="F Nd Kl">Ebru F Nd Kl</name>
<name sortKey="Kuruta, Ergul Belge" sort="Kuruta, Ergul Belge" uniqKey="Kuruta E" first="Ergül Belge" last="Kuruta">Ergül Belge Kuruta</name>
</noCountry>
<country name="Turquie"><noRegion><name sortKey="Sahin, Nilfer" sort="Sahin, Nilfer" uniqKey="Sahin N" first="Nilfer" last="Sahin">Nilfer Sahin</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000981 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000981 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= MersV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:29659348 |texte= Evaluation of estrogen and G protein-coupled estrogen receptor 1 (GPER) levels in drug-naïve patients with attention deficit hyperactivity disorder (ADHD). }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:29659348" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a MersV1
This area was generated with Dilib version V0.6.33. |